Top Stories ArriVent BioPharma Reports Earnings Beat, Shares Drop 7.2% ArriVent BioPharma (NASDAQ: AVBP) announced its quarterly earnings on December 5, 2023, reporting a loss of $0.78 per share. This result surpassed analysts’ expectations,... Editorial6 March, 2026